March 25, 2017
Recommended Topic Related To:

Cosopt

"The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter "...

A A A

Cosopt




Overdosage
Contraindications

OVERDOSE

Symptoms consistent with systemic administration of beta-blockers or carbonic anhydrase inhibitors may occur, including electrolyte imbalance, development of an acidotic state, dizziness, headache, shortness of breath, bradycardia, bronchospasm, cardiac arrest and possible central nervous system effects. Serum electrolyte levels (particularly potassium) and blood pH levels should be monitored. [See ADVERSE REACTIONS]

A study of patients with renal failure showed that timolol did not dialyze readily.

CONTRAINDICATIONS

Asthma, COPD

COSOPT is contraindicated in patients with bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease [see WARNINGS AND PRECAUTIONS].

Sinus Bradycardia, AV Block, Cardiac Failure, Cardiogenic Shock

COSOPT is contraindicated in patients with sinus bradycardia, second or third degree atrioventricular block, overt cardiac failure, and cardiogenic shock [see WARNINGS AND PRECAUTIONS].

Hypersensitivity

COSOPT is contraindicated in patients who are hypersensitive to any component of this product [see WARNINGS AND PRECAUTIONS].

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 11/4/2016

Overdosage
Contraindications

Cosopt - User Reviews

Cosopt User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Cosopt sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.